Biomarin Pharmaceutical Inc (BMRN)
75.08
+0.60
(+0.81%)
USD |
NASDAQ |
May 31, 16:00
75.07
-0.01
(-0.01%)
After-Hours: 20:00
Biomarin Pharmaceutical 1 Year Total Returns (Daily): -13.64% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 31, 2024 | -13.64% |
| May 30, 2024 | -14.61% |
| May 29, 2024 | -15.17% |
| May 28, 2024 | -15.88% |
| May 24, 2024 | -16.59% |
| May 23, 2024 | -17.49% |
| May 22, 2024 | -17.59% |
| May 21, 2024 | -15.84% |
| May 20, 2024 | -16.16% |
| May 17, 2024 | -15.94% |
| May 16, 2024 | -16.36% |
| May 15, 2024 | -15.53% |
| May 14, 2024 | -15.20% |
| May 13, 2024 | -14.30% |
| May 10, 2024 | -14.83% |
| May 09, 2024 | -14.53% |
| May 08, 2024 | -14.71% |
| May 07, 2024 | -14.54% |
| May 06, 2024 | -15.04% |
| May 03, 2024 | -11.90% |
| May 02, 2024 | -10.68% |
| May 01, 2024 | -14.08% |
| April 30, 2024 | -15.91% |
| April 29, 2024 | -14.48% |
| April 26, 2024 | -13.00% |
| Date | Value |
|---|---|
| April 25, 2024 | -14.02% |
| April 24, 2024 | -5.16% |
| April 23, 2024 | -5.59% |
| April 22, 2024 | -8.22% |
| April 19, 2024 | -10.53% |
| April 18, 2024 | -8.47% |
| April 17, 2024 | -9.80% |
| April 16, 2024 | -8.22% |
| April 15, 2024 | -7.58% |
| April 12, 2024 | -5.86% |
| April 11, 2024 | -6.52% |
| April 10, 2024 | -8.00% |
| April 09, 2024 | -10.66% |
| April 08, 2024 | -12.37% |
| April 05, 2024 | -9.96% |
| April 04, 2024 | -8.95% |
| April 03, 2024 | -10.17% |
| April 02, 2024 | -10.74% |
| April 01, 2024 | -10.43% |
| March 28, 2024 | -4.48% |
| March 27, 2024 | -3.16% |
| March 26, 2024 | -3.31% |
| March 25, 2024 | -4.65% |
| March 22, 2024 | -5.50% |
| March 21, 2024 | -8.66% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-39.33%
Minimum
Jul 20 2021
64.77%
Maximum
Aug 14 2020
0.38%
Average
-0.04%
Median
Mar 04 2022
1 Year Total Returns (Daily) Benchmarks
| Pfizer Inc | -20.36% |
| Ligand Pharmaceuticals Inc | 21.56% |
| Blueprint Medicines Corp | 86.68% |
| Bristol-Myers Squibb Co | -33.50% |
| Alnylam Pharmaceuticals Inc | -19.77% |